The University of Warwick Library - WebBridge
Neo-tAnGo: a neoadjuvant randomized phase III trial of epirubicin/cyclophosphamide and paclitaxel +/- gemcitabine in the treatment of women with high-risk early breast cancer (EBC): first report of the primary endpoint, pathological complete response (pCR)
Earl, Helena M.. 45th Annual Meeting of the American Society of Clinical Oncology. v. Vol.27. no. No.15 Suppl. S. 2009-05-20. p. 60 - issn: 0732-183X .
Sorry - based on the information provided, WebBridge cannot offer appropriate links.